From: New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles’ operation
Patient No | Age | PSA (ng/mL) | Prostate volume (mL) | PSAD (ng/mL2) | Biopsy (year) | 3 T MRI | TPUS | ||
---|---|---|---|---|---|---|---|---|---|
Scanner | Coil | Scanner | Probe | ||||||
1 | 71 | 23.61 | 21.1 | 1.12 | 2009 | Achieva (PH) | Surface | IU 22 (PH) | C9 5ec (PH) |
2 | 77 | 6.19 | 92.1 | 0.07 | 2012 | Achieva (PH) | Surface | IU 22 (PH) | C9 5ec (PH) |
3 | 70 | 11.92 | 19.4 | 0.61 | 2016 | Skyra (SH) | Surface | IU 22 (PH) | C9 5ec (PH) |
4 | 72 | 22.60 | 19.8 | 1.14 | 2017 | Achieva (PH) | Surface | IU 22 (PH) | C9 5ec (PH) |
5 | 66 | 25.29 | 17.4 | 1.45 | 2019 | Achieva (PH) | Surface | IU 22 (PH) | C9 5ec (PH) |
6 | 78 | 22.69 | 27.8 | 0.82 | 2020 | Achieva (PH) | Surface | EPIC (PH) | C10 4ec (PH) |
7 | 71 | 11.70 | 56.3 | 0.21 | 2020 | Ingenia CX (PH) | Surface | EPIC (PH) | C10 4ec (PH) |
8 | 64 | 69.70 | 26.8 | 2.60 | 2021 | Ingenia CX (PH) | Surface | EPIC (PH) | C10 4ec (PH) |
9 | 61 | 10.10 | 53.0 | 0.19 | 2022 | Magnetom Vida (SH) | Surface | EPIC (PH) | C10 4ec (PH) |